Routine annual meeting results with no material news. Monitor future 8-Ks for stock option grants under the new plan, which may indicate dilution. Current analyst consensus is 91% bullish, but this filing provides no catalyst for near-term price movement.
Price Chart
Executive Summary
Apyx Medical Corp held its 2026 Annual Meeting on August 6, 2026. Stockholders approved all four proposals: election of all five directors, ratification of RSM US LLP as auditor, a non-binding advisory vote on named executive officer compensation, and the adoption of the 2026 Share Incentive Plan, which authorizes up to 4,000,000 new shares for equity awards. This is a routine governance filing—stockholder approval of a new equity plan for employee retention—and carries no immediate financial or operational impact.
Key Facts
- Stockholders approved the 2026 Share Incentive Plan authorizing 4,000,000 shares for option and restricted stock grants.
- All five director nominees were elected: Stavros G. Vizirgianakis, Charles D. Goodwin, Lawrence J. Waldman, Minnie Baylor-Henry, and Wendy Levine.
- RSM US LLP ratified as independent auditor for FY2026 (29,814,618 for, 31,610 against).
- Non-binding say-on-pay passed with 21,458,554 votes for, 669,298 against.
- No material financial data, guidance, or changes to business operations reported.
Financial Impact
No direct financial impact. The plan authorizes up to 4,000,000 shares for equity compensation, representing potential future dilution of approximately 4-6% of currently outstanding shares, but no grants have been made.
Risk Factors
- Potential future dilution from up to 4 million new shares authorized under the equity plan.
- No financial results or guidance included in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-036557 |
| Document: form8-k.htm | 0001493152-26-036557 |
| Document: 0001493152-26-036557-index-headers.html | 0001493152-26-036557 |
| Document: 0001493152-26-036557-index.html | 0001493152-26-036557 |
| Document: 0001493152-26-036557.txt | 0001493152-26-036557 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $2.41 | awaiting T+20 | — | $2.46 (+2.07%) |
Aug 7, 2026 11w ago | 8-K | $3.46 $3.05 | ▼ −11.85% | ▼ −10.94% | $2.46 (−28.90%) |
May 21, 2026 22w ago | 8-K | $4.13 $3.95 | ▼ −4.36% | ▼ −2.94% | $2.46 (−40.44%) |
May 21, 2026 22w ago | Press Release | $4.25 $4.04 | ▼ −4.94% | ▼ −5.27% | $2.46 (−42.12%) |
May 14, 2026 23w ago | 8-K | $4.36 $4.69 | ▲ +7.57% | ▲ +8.43% | $2.46 (−43.58%) |
May 11, 2026 24w ago | 8-K | $3.92 $4.86 | ▲ +23.98% | ▲ +24.28% | $2.46 (−37.24%) |
Apr 23, 2026 26w ago | Press Release | $3.80 $3.79 | ▼ −0.26% | ▼ −4.90% | $2.46 (−35.26%) |
Mar 10, 2026 32w ago | Press Release | $3.45 $3.81 | ▲ +10.43% | ▲ +10.59% | $2.46 (−28.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers